Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|April 18, 2008
An assessment of linezolid utilization in selected canadian provincesSandra Walker, Linda Dresser, Debbie Becker, et al.The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 15, 2014
Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of careAnjie Yang, Ron Fung, James Brunton, et al.Clinical Pharmacokinetics|February 2, 2023
Pharmacokinetic Alterations Associated with Critical IllnessDiana Morales Castro, Linda Dresser, John Granton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in CanadaSandra R Knowles, Elizabeth J Phillips, Linda Dresser, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2017
Residual Kidney Function and Peritoneal Dialysis-Associated Peritonitis Treatment OutcomesRachel Whitty, Joanne M Bargman, Alex Kiss, et al.Infection Control and Hospital Epidemiology|April 6, 2012
Use of a structured panel process to define quality metrics for antimicrobial stewardship programsAndrew M Morris, Stacey Brener, Linda Dresser, et al.Plos One|March 6, 2020
Barriers and facilitators to the uptake of an antimicrobial stewardship program in primary care: A qualitative studyLianne Jeffs, Warren McIsaac, Michelle Zahradnik, et al.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
A Canadian perspective on the revised 2020 ASHP-IDSA-PIDS-SIDP guidelines for vancomycin AUC-based therapeutic drug monitoring for serious MRSA infectionsJackson J Stewart, Sarah Cj Jorgensen, Linda Dresser, et al.Pharmacotherapy|March 27, 2007
Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndromeMatthew P Muller, Linda Dresser, Janet Raboud, et al.European Journal of Drug Metabolism and Pharmacokinetics|May 7, 2026
Kinetics of Sevoflurane Vaporized Directly in Extracorporeal Membrane Oxygenators-Ex Vivo Findings and Pharmacokinetic/Pharmacodynamic SimulationsDiana Morales Castro, Mark Alm, Federico Carlos Carini, et al.Pageof 2